Cancer Drug Resistance: 'New' Estrogen Receptor Found To Be Key Player In Tamoxifen Resistance
Thursday, October 30, 2008 - 08:28
in Health & Medicine
Researchers have discovered a novel way in which breast cancer cells become resistant to tamoxifen, the world's largest-selling breast cancer prevention and treatment drug. They say the findings could provide a way to identify tamoxifen users who are no longer benefiting from the drug, allowing doctors to try another therapy option sooner.
Read the whole article on Science Daily
More from Science Daily
Related
- 'New' estrogen receptor found to be key player in tamoxifen resistanceThu, 30 Oct 2008, 6:57:00 EDT
- Identifying the potential for tamoxifen resistance in patientsWed, 10 Jun 2009, 16:43:34 EDT
- Previously unseen switch regulates breast cancer response to estrogenThu, 8 May 2008, 15:07:32 EDT
- Tamoxifen chemoprevention tied to early detection of breast cancerTue, 7 Oct 2008, 16:36:23 EDT
- Novel basis identified for tamoxifen failureThu, 4 Dec 2008, 4:37:28 EST